化学抗原受容体マクロファージ療法 が 臨床 に 入る: HER2+ の 固形 腫瘍 に 関する 第 一 次 の 人体 試験
Wenxue Ma1, Catriona Jamieson1,2
1Department of Medicine Sanford Stem Cell Institute Moores Cancer Center University of California San Diego La Jolla California USA.
MedComm
|September 2, 2025
まとめ
No abstract available in PubMed .
関連する概念動画
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.